del Nido与冷血心脏停搏液在主动脉瓣置换术中的随机试验
该随机试验纳入150例主动脉瓣置换术患者,比较del Nido与冷血心脏停搏液的心肌保护效果。主要终点为阻断期间电活动、再灌注室颤及术后24和48小时肌钙蛋白和CK-MB。
要点
- 两组阻断期间电活动无显著差异(39.7% vs 45.3%,调整P=1.0)。
- 术后24和48小时肌钙蛋白及CK-MB两组无显著差异。
核心结论
- del Nido心脏停搏液方案可作为主动脉瓣置换术中冷血心脏停搏液的 acceptable 替代选择。
研究设计与样本
- 随机试验纳入150例主动脉瓣置换术患者,随机分为del Nido组或冷血心脏停搏液组。
- del Nido停搏液每90分钟一次,冷血停搏液每20-30分钟一次或观察到心脏活动时给予。
主要发现
- 阻断期间电活动:del Nido组29例(39.7%)vs 冷血组34例(45.3%),调整P=1.0。
- 24小时肌钙蛋白中位数:del Nido组223.10 pg/mL(IQR 168.35-364.77)vs 冷血组285.5 pg/mL(IQR 196.20-419.45),无显著性。
- 48小时肌钙蛋白中位数:del Nido组159.60 pg/mL(IQR 125.42-217.20)vs 冷血组201.60 pg/mL(IQR 160.62-268.45),无显著性。
- 24小时CK-MB中位数:del Nido组14.94 ng/mL(IQR 12.16-20.39)vs 冷血组17.43 ng/mL(IQR 13.66-22.43),无显著性;48小时CK-MB中位数:del Nido组6.19 ng/mL(IQR 4.41-7.63)vs 冷血组7.38 ng/mL(IQR 4.74-10.20),无显著性。
关键数值与推荐
- del Nido停搏液每90分钟给药一次;冷血停搏液每20-30分钟给药一次或心脏活动时给药。
- 主要终点为阻断期间电活动、再灌注室颤及术后24和48小时肌钙蛋白和CK-MB。
临床怎么用
- 对于主动脉瓣置换术患者,del Nido停搏液可减少再灌注室颤发生率,且不增加心肌损伤标志物。
- del Nido停搏液给药间隔较长(90分钟),可能简化手术流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the cardioprotective efficacy of a solution that requires only a single infusion at the start of the ischemic duration versus a solution that requires multiple infusions. METHODS: Aortic valve replacement was performed for 150 patients, who were randomized into the del Nido (DN) cardioplegia group or the cold blood (CB) cardioplegia group. The DN cardioplegia was delivered every 90 minutes and the CB cardioplegia was delivered every 20 to 30 minutes, or whenever cardiac activity was observed. The primary endpoints were electrical cardiac activity during crossclamp, ventricular fibrillation during reperfusion, and postoperative troponin and creatine kinase (CK-MB isoenzyme) at 24 and 48 hours. RESULTS: Electrical activity during crossclamp occurred in 29 (39.7%) patients in the DN group versus 34 (45.3%) patients in the CB group (adjusted P = 1.0). The number of procedures with ventricular fibrillation after removing the crossclamp was 41 (54.7%) in the CB group versus 17 (22.7%) in the DN group (adjusted P = .001; relative risk, 2.41). Troponin values appeared to be lower in the DN group (median, 223.10; interquartile range, 168.35-364.77 pg/mL vs 285.5; 196.20-419.45 pg/mL at 24 hours and 159.60; 125.42-217.20 pg/mL vs 201.60; 160.62-268.45 pg/mL at 48 hours) and CK-MB (median, 14.94; interquartile range, 12.16-20.39 ng/mL vs 17.43; 13.66-22.43 ng/mL at 24 hours and 6.19; 4.41-7.63 ng/mL vs 7.38; 4.74-10.20 ng/mL at 48 hours), but no significance was found. CONCLUSIONS: The del Nido cardioplegia protocol is an acceptable alternative for cold blood cardioplegia in patients undergoing aortic valve replacement.
引用
- Sanetra K, Gerber W, Shrestha R, et al. The del Nido versus cold blood cardioplegia in aortic valve replacement: A randomized trial. J Thorac Cardiovasc Surg. 2019. PMID: 31358336. doi:10.1016/j.jtcvs.2019.05.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。